Dr Lal Path Labs

Stocks to Watch Today: Coforge, NCC, Kotak Bank, GPT Infra, Vikran Engineering, Eclerx, Container Corporation, RailTel, Thyrocare, IOC in focus on 27 October

Stocks to Watch, 27 October: Stocks like Kotak Mahindra Bank, Dr Reddy's Laboratories, SBI Life Insurance Company, Coforge, eClerx Services, Zydus Lifesciences, TGV Sraac, NCC,GPT Infraprojects, Epack Prefab Technologies, Vikran Engineering, RailTel Corporation of India, and Indian Oil Corporation will be in focus on October 27.

Dr Lal PathLabs: Exit of a company veteran stokes investor concerns

Om Manchanda, managing director of Lal PathLabs, is moving on to an advisory role after steering the company for close to two decades

Dr Lal PathLabs shares shed 6% amid profit booking after firm's Q2 net profit jumps 18%

Dr Lal PathLabs stock has been losing for the last two days and has fallen 7.34 percent in the period.

Dr Lal PathLabs Q1 profit up 29% at Rs 108 cr

The company had reported a profit after tax of Rs 84 crore in the April-June quarter of the last fiscal

Can Dr Lal PathLabs, Metropolis brave competition from new-age diagnostic rivals?

New-age players, in spite of cutting down on discounts, are seeing significantly higher revenue growth than incumbents.

Dr Lal PathLabs jumps 5% on double upgrade from Kotak Institutional Equities

Dr Lal PathLabs shares were trading at Rs 2,234.65, up nearly 5 percent from the previous close. The revised price target implies an upside of 8 percent from March 22 closing

Bonanza Portfolio's top stock picks amid ongoing market slump; check here

Bonanza Portfolio’s Omkar Kamtekar recommended investors buy into Dr Lal Path Labs, PCBL and Aavas Financers during the market downturn.

Why Dr Lal PathLabs’ fat profit margins are bringing no cheer

Business volumes lagged expectations as patient footfalls are largely unchanged in Q1 FY24 from year ago period